Clinical trial Recruiting at 1 site Observational Ages 18 and up

Detecting infections in fractures around joint implants

Official title: Investigating Periprosthetic Fracture Culture Positivity in Patients With Hip and Knee Arthroplasties

Run by University of Chicago · NCT06952738 · Data updated 2026-11-12

This project will test whether routine blood tests, synovial fluid analysis, and extended joint and tissue cultures can find infections in adults who have fractures around hip or knee replacements and need surgery.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversity of Chicago
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedApril 30, 2027
Study endsOctober 31, 2027
Registry record updatedDecember 22, 2025
Trial IDNCT06952738 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with periprosthetic fractures around primary or revision hip or knee implants who require operative management and present to the University of Chicago during the October 2025 to October 2027 enrollment window.

Probably not a fit

Patients treated non-operatively, those with any prior prosthetic joint infection of the involved joint, or those presenting with a sinus tract are excluded and unlikely to benefit from the testing protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients with periprosthetic fractures who require operative management will undergo standard preoperative imaging and inflammatory blood tests (CRP and ESR). Intraoperative synovial fluid will be analyzed for white blood cell count and PMN percentage, and three cultures from joint fluid and peri-implant tissue will be incubated for 14 days for aerobic, anaerobic, fungal, and AFB organisms. Samples and results will be interpreted alongside Musculoskeletal Infection Society (MSIS) criteria to identify infection and clinical factors that predict positive cultures. No additional advanced imaging will be obtained solely for the project and all testing follows the surgeons' standard-of-care protocols.

Why it matters

Potential benefit: If successful, this approach could create clearer diagnostic rules for infection in periprosthetic fractures, reducing missed infections and guiding more appropriate surgical and antibiotic treatment.

How similar studies have gone: Prior work in prosthetic joint infection has shown that synovial analysis and prolonged cultures can improve pathogen detection, but applying these methods specifically to periprosthetic fractures is less well established and relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (\>18 years old) with periprosthetic fractures around primary or revision hip or knee arthroplasty
* Patients requiring operative management for these fractures (fixation or revision arthroplasty)
* Patients presenting to the University of Chicago Medical Center during two (2) year period (October 2025 to October 2027)

Exclusion Criteria:

* Patients undergoing non-operative management for periprosthetic fractures
* Any documented or reported history of past prosthetic joint infection of the involved joint
* Sinus tract at the time of presentation at the involved joint

Where it's running

  • The University of Chicago Medical Center
    Chicago, Illinois, United States
    Recruiting

Study contacts

  • Principal investigator: Sara Wallace, MD — The University of Chicago Department of Orthopaedic Surgery
  • Study coordinator: Malik J Scott, BA
  • Email: mjscott1@uchicago.edu
  • Phone: 773-834-0822

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.